John Kim

6.1k citations
119 papers · 3.9k · 3 hit papers · h-index 32

Impact in

Papers in

John Kim

111 papers receiving 3.8k citations

John Kim's Hit Papers

Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age 2023 · 162 citations
1620+7+15Years since publication100200300400

Peers

John Kim
Comparison fields: 5 of 163
  • Health Informatics 360
  • Virology 219
  • Cancer Research 572
  • Infectious Diseases 653
  • Aging 57
Replace Shinya Fukumoto with:
Shinya Fukumoto Japan
Wilson Liao United States
Ian Sabroe United Kingdom
Leonard C. Harrison Australia
Giorgio Sirugo United States
Huey‐Kang Sytwu Taiwan
Mayte Suárez‐Fariñas United States
Heidi Spratt United States
Kent D. Taylor United States
John Kim relative to Shinya Fukumoto Japan Shinya Fukumoto's profile →
Citations per field
00.5×10×14.4×
Shinya Fukumoto · 1×
Citations per year

Countries citing papers authored by John Kim

Since Specialization
Citations

This map shows the geographic impact of John Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Kim more than expected).

Fields of papers citing papers by John Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Kim. The network helps show where John Kim may publish in the future.

Co-authors

The 25 scholars most cited alongside John Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Kim Line = papers co-authored together John Kim links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Identification of many microRNAs that copurify with polyribosomes in mammalian neurons
Hit paper breakdown →
2003470
2 2003238
3
Assessing the Utility of ChatGPT Throughout the Entire Clinical Workflow: Development and Usability Study
Hit paper breakdown →
2023228
4 2023189
5 2011171
6 2006171
7
Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age
Hit paper breakdown →
2023162
8 1994148
9 2012137
10 200594
11 200692
12 201090
13 199786
14 199364
15 201463
16 200659
17 202055
18 201155
19 202255
20 200755

About John Kim

John Kim is a scholar working on Infectious Diseases, Molecular Biology, Epidemiology, Surgery and Immunology, having authored 119 papers that have together received 3.9k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (10 papers), Tuberculosis Research and Epidemiology (9 papers), HIV Research and Treatment (8 papers), Hepatitis C virus research (8 papers), HIV/AIDS drug development and treatment (7 papers), Hepatitis B Virus Studies (5 papers), HIV, Drug Use, Sexual Risk (5 papers) and Infectious Diseases and Tuberculosis (5 papers). The work is most often cited by research in Health Informatics (360 citations), Virology (219 citations), Cancer Research (572 citations), Infectious Diseases (653 citations) and Aging (57 citations). John Kim has collaborated with scholars based in United States, Canada and South Korea. Frequent co-authors include Gabriel D. Hayes, George M. Church, Gary Ruvkun, Yonatan H. Grad, Anna M. Krichevsky, Kenneth S. Kosik, Arya Rao, Marc D. Succi, Michael Pang and Winston Lie. Their work appears in journals such as Radiographics, Blood, Vaccine, Proceedings of the National Academy of Sciences and Archives of Pharmacal Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact